Aclarion (ACON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
More News
Aclarion, Inc. (ACON) Reports Q1 Loss, Misses Revenue Estimates
Aclarion (ACON) delivered earnings and revenue surprises of +13.55% and -29.53%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Sonida Senior Living (SNDA) Reports Q1 Loss, Tops Revenue Estimates
Sonida Senior Living (SNDA) delivered earnings and revenue surprises of -43.11% and +24.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Natera (NTRA) delivered earnings and revenue surprises of -5.26% and +13.26%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Teladoc (TDOC) delivered earnings and revenue surprises of -13.82% and +0.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Aclarion Authorized To Repurchase Up To $2.5 Mln Of Shares
false
Nasdaq News: Markets
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes
CEO Brent Ness noted a broad global market, with approximately 266 million people affected by chronic low back pain.
Stocktwits
S&P 500, Nasdaq Futures Waver Ahead Of Supreme Court Ruling On Trump Tariffs: Why OPEN, ACON, FLYX, OSCR Are Trending After-Hours
Attention also centered on Trump’s comments on proposed mortgage bond purchases.
Stocktwits
Healthcare Stocks To Keep An Eye On - January 8th
UnitedHealth Group, Johnson & Johnson, Intuitive Surgical, Aclarion, and Hims & Hers Health are the five Healthcare stocks to watch today, according to MarketBeat's stock screener tool. As it...
MarketBeat
ACON Stock Pops 45% Pre-Market Today: What’s Driving The Move?
The company said demand for Nociscan continued to accelerate through 2025, with scan volumes rising sharply across the U.S., the U.K., and Europe as new imaging centers and physician users came onboard.